Recon: Moderna lifts guidance on COVID vaccine sales; US backing of patent waiver causes stir
The Pharma Data
MAY 6, 2021
Moderna booster increases antibodies against COVID-19 variants, early data shows ( Reuters ). Taking double Covid-19 hits, Merck writes off $170M for scrapped drug, highlights $600M in missed sales ( Endpoints ). CSL closes deal for UniQure gene therapy in hopeful sign for M&A ( BioPharmaDive ).
Let's personalize your content